HMBA ameliorates obesity by MYH9‐ and ACTG1‐dependent regulation of hypothalamic neuropeptides

Abstract The global epidemic of obesity remains a daunting problem. Here, we report hexamethylene bisacetamide (HMBA) as a potent anti‐obesity compound. Peripheral and central administration of HMBA to diet‐induced obese mice regulated the expression of hypothalamic neuropeptides critical for energy...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Seokjae Park, Sungjoon Oh, Nayoun Kim, Eun‐Kyoung Kim
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Springer Nature 2023-11-01
Saila:	EMBO Molecular Medicine
Gaiak:	ACTG1 anti‐obesity hexamethylene bisacetamide hypothalamic neuropeptides MYH9
Sarrera elektronikoa:	https://doi.org/10.15252/emmm.202318024
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!